Detalhe da pesquisa
1.
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug.
Mol Ther
; 28(8): 1759-1771, 2020 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32592692
2.
Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.
Mol Ther
; 25(12): 2705-2714, 2017 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28882451
3.
Treatment of Liver Cancer by C/EBPA saRNA.
Adv Exp Med Biol
; 983: 189-194, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28639200
4.
Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic Syndrome.
Nucleic Acid Ther
; 32(6): 486-496, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895511
5.
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial.
Clin Cancer Res
; 26(15): 3936-3946, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32357963
6.
Expression profile of CREB knockdown in myeloid leukemia cells.
BMC Cancer
; 8: 264, 2008 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-18801183
7.
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.
Oncogene
; 37(24): 3216-3228, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29511346
8.
Putative immunogenicity expression profiling using human pluripotent stem cells and derivatives.
Stem Cells Transl Med
; 4(2): 136-45, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25575527
9.
Gene Expression Profile Changes After Short-activating RNA-mediated Induction of Endogenous Pluripotency Factors in Human Mesenchymal Stem Cells.
Mol Ther Nucleic Acids
; 1: e35, 2012 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23344177